Keywords: UFH، هپارین غیر اشباع شده; hMSCs, human bone marrow-derived mesenchymal stem cells; RNA-seq, high throughput next generation RNA sequencing; FGF, fibroblast growth factor; HBD, heparin-binding domain; VEGFs, vascular endothelial factors; UFH, unfractionated heparin; LMWH, low-molec
مقالات ISI UFH، هپارین غیر اشباع شده (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: UFH، هپارین غیر اشباع شده; Deep vein thrombosis; Perioperative thromboprophylaxis; Pulmonary embolismDVT, deep vein thrombosis; LMWH, low molecular weight heparin; PE, pulmTonary embolism; UFH, unfractionated heparin; US, ultrasound; VKA, vitamin K anatagonist; VTE, venous thromboe
Cerebral Embolism During Transcatheter Aortic Valve Replacement : The BRAVO-3 MRI Study
Keywords: UFH، هپارین غیر اشباع شده; stenosis; stroke; valvuloplastyCI, confidence interval; DW, diffusion-weighted; IQR, interquartile range; MRI, magnetic resonance imaging; TAVR, transcatheter aortic valve replacement; UFH, unfractionated heparin
Unfractionated heparin attenuates LPS-induced IL-8 secretion via PI3K/Akt/NF-κB signaling pathway in human endothelial cells
Keywords: UFH، هپارین غیر اشباع شده; UFH, unfractionated heparin; HPMEC, human pulmonary microvascular endothelial cells; LPS, lipopolysaccharide; PI3K, phosphoinositide-3-kinase; NF-κB, nuclear factor-κB; IL, interleukinUnfractionated heparin; Lipopolysaccharide; Phosphoinositide-3-kinase;
Unfractionated heparin suppresses lipopolysaccharide-induced monocyte chemoattractant protein-1 expression in human microvascular endothelial cells by blocking Krüppel-like factor 5 and nuclear factor-κB pathway
Keywords: UFH، هپارین غیر اشباع شده; UFH, unfractionated heparin; HPMEC, human pulmonary microvascular endothelial cells; MCP-1, monocyte chemoattractant protein-1; KLF5, Krüppel-like factor 5; NF-κB, nuclear factor-κB; IL-8, interleukin-8Unfractionated heparin; Sepsis; Endothelial cells; Mo
Evaluation of Weight-Based Dosing of Unfractionated Heparin in Obese Children
Keywords: UFH، هپارین غیر اشباع شده; ACT, Activated clotting time; aPTT, Activated partial thromboplastin time; BMI, Body mass index; UFH, Unfractionated heparin; Xa, Activated factor X
A Kunitz-type FXa inhibitor affects tumor progression, hypercoagulable state and triggers apoptosis
Keywords: UFH، هپارین غیر اشباع شده; Amblyomin-X; Heparin; Antitumor; Apoptosis; Coagulation; Cell cycleLMWHs, low-molecular-weight heparins; UFH, unfractionated heparin; TFPI, tissue factor pathway inhibitor; PT, prothrombin time; APPT, activated partial thromboplastin time; FXa, active Fac
Clinical Impact of a Value-Based Decision: A Surgical Case Study
Keywords: UFH، هپارین غیر اشباع شده; BP, best practice; C/D, cost per dose; DVT, deep venous thrombophlebitis; LMWH, low molecular weight heparin; OR, operating room; PE, pulmonary embolism; SCD, sequential compression device; UFH, unfractionated heparin; VBA, value-based analysis; VPMA, Vic
Clinical Outcomes Following Stent Thrombosis Occurring In-Hospital Versus Out-of-Hospital : Results From the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) Trial
Keywords: UFH، هپارین غیر اشباع شده; PCI; STEMI; stent thrombosisGPI, glycoprotein IIb/IIIa inhibitor; PCI, percutaneous coronary intervention; ST, stent thrombosis; STEMI, ST-segment elevation myocardial infarction; TIMI, Thrombolysis In Myocardial Infarction; UFH, unfractionated heparin
Quantification of unfractionated heparin in human plasma and whole blood by means of novel fluorogenic anti-FXa assays
Keywords: UFH، هپارین غیر اشباع شده; UFH, unfractionated heparin; FXa, factor Xa; APTT, activated partial thromboplastin time; ACT, activated clotting time; AMC, 7-amino-4-methylcoumarin; SN-7, Mes-D-LGR-ANSN (C2H5)2 fluorogenic substrate; ANSN, 6-amino-1-naphthalene-sulfonamide; DCU, Dublin
Analysis of unfractionated heparin dose requirements to target therapeutic anti-Xa intensity during pregnancy
Keywords: UFH، هپارین غیر اشباع شده; AC, anticoagulant; VTE, venous thromboembolism; LMWH, low-molecular-weight heparin; UFH, unfractionated heparin; aPTT, activated partial thromboplastin time; KPCO, Kaiser Permanente Colorado; CPAS, Clinical Pharmacy Anticoagulation Service; IV, intravenou
Direct comparison of enoxaparin and nadroparin in a rabbit model of arterial thrombosis prevention
Keywords: UFH، هپارین غیر اشباع شده; UFH, unfractionated heparin; LMWH's, low molecular weight heparins; APTT, activated partial thromboplastin time; TCT, thrombin clotting timeHemostasis; Blood coagulation; Heparin; Low molecular weight heparins; Animal model
Catheter-related thrombosis in children with intestinal failure and long-term parenteral nutrition: How to treat and to prevent?
Keywords: UFH، هپارین غیر اشباع شده; PN, Parenteral nutrition; CI, Confidential Interval; SVC, Superior vena cava; OR, Odds Ratio; SE, Standard Error; PTS, Post thrombotic syndrome; LMWH, Low-molecular-weight heparin; UFH, Unfractionated heparin; INR, International normalized ratioIntestinal
Heparin versus prostacyclin in continuous hemodiafiltration for acute renal failure: Effects on platelet function in the systemic circulation and across the filter
Keywords: UFH، هپارین غیر اشباع شده; PGI, prostacyclin analogue; UFH, unfractionated heparin; CVVHDF, continuous venovenous hemodiafiltration; ARF, acute renal failure; OPA, optical platelet aggregometry; Tmax, maximal aggregation; ICU, intensive care unit; ADP, adenosine 5'-diphosphate; aPT
In vivo age dependency of unfractionated heparin in infants and children
Keywords: UFH، هپارین غیر اشباع شده; UFH, Unfractionated Heparin; ETP, Endogenous Thrombin Potential; AT, Antithrombin; APTT, Activated Partial Thromboplastin TimeUnfractionated Heparin; Children; Anti-Xa; ETP; APTT
Comparison of Safety and Efficacy of Bivalirudin Versus Unfractionated Heparin in Percutaneous Peripheral Intervention: A Single-Center Experience
Keywords: UFH، هپارین غیر اشباع شده; bivalirudin; heparin; percutaneous peripheral interventionACT, activated clotting time; GP, glycoprotein; PCI, percutaneous coronary intervention; PPI, percutaneous peripheral intervention; PRBC, packed red blood cells; UFH, unfractionated heparin
Development of a real-time PCR detection method for a FCGR2A polymorphism in the LightCycler and application in the heparin-induced thrombocytopenia syndrome
Keywords: UFH، هپارین غیر اشباع شده; FCGR2A, Fc gamma receptor IIa; HIT, heparin-induced thrombocytopenia; HITT, heparin-induced thrombocytopenia and thrombosis; UFH, unfractionated heparin; LMWH, low molecular weight heparin; DVT, deep vein thrombosis; PE, pulmonary embolism; TECs, thromboe
Feasibility of an easy-to-use risk score in the prevention of venous thromboembolism and placental vascular complications in pregnant women: A prospective cohort of 2736 women
Keywords: UFH، هپارین غیر اشباع شده; BID, twice daily; CI, confidence interval; DVT, deep-vein thrombosis; LMWH, low-molecular-weight heparin; PE, pulmonary embolism; UFH, unfractionated heparin; VTE, venous thromboembolism.Low-molecular-weight heparin; Obstetrical complications; Pregnancy;
Heparin-induced thrombocytopenia: A stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings
Keywords: UFH، هپارین غیر اشباع شده; UFH, unfractionated heparin; LMWH, low-molecular weight heparin; HIT, heparin-induced thrombocytopenia; PF4, platelet factor 4; AT, antithrombin; PCS, photon correlation spectroscopy; aXaU, anti-factor Xa units; MW, molecular weight.Heparin-induced thromb
Peri-Procedural Platelet Function and Platelet Inhibition in Percutaneous Coronary Intervention
Keywords: UFH، هپارین غیر اشباع شده; ADP, adenosine diphosphate; COX, cyclooxgenase; GP, glycoprotein; MACE, major adverse cardiac events; PAR, protease-activated receptor; PCI, percutaneous coronary intervention; UFH, unfractionated heparin
Acute generalized exanthematous pustulosis from dalteparin
Keywords: UFH، هپارین غیر اشباع شده; AGEP, acute generalized exanthematous pustulosis; LMWH, low molecular–weight heparin; UFH, unfractionated heparin
The Impact of Renal Dysfunction on Outcomes in the ExTRACT-TIMI 25 Trial
Keywords: UFH، هپارین غیر اشباع شده; CI, confidence interval; CrCl, creatinine clearance; ENOX, enoxaparin; LMWH, low-molecular-weight heparin; MI, myocardial infarction; ORadj, adjusted odds ratio; STEMI, ST-segment elevation myocardial infarction; UFH, unfractionated heparin
Relative quantification of glycosaminoglycan-induced upregulation of TFPI-mRNA expression in vitro
Keywords: UFH، هپارین غیر اشباع شده; AU, arbitrary units; CS, chondroitin sulfate; GAG, glycosaminoglycan; HS, heparan sulfate; Lp(a), lipoprotein(a); LMWH, low-molecular-weight heparin; UFH, unfractionated heparin; TF, tissue factor; TFPI, tissue factor pathway inhibitorTissue factor pathwa
Percutaneous Coronary Intervention in Patients Receiving Enoxaparin or Unfractionated Heparin After Fibrinolytic Therapy for ST-Segment Elevation Myocardial Infarction in the ExTRACT-TIMI 25 Trial
Keywords: UFH، هپارین غیر اشباع شده; ENOX, enoxaparin; PCI, percutaneous coronary intervention; STEMI, ST-segment elevation myocardial infarction; UFH, unfractionated heparin
Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Results From the OASIS-5 Trial
Keywords: UFH، هپارین غیر اشباع شده; ACS, acute coronary syndrome; ACT, activated clotting time; CI, confidence interval; GP, glycoprotein; HR, hazard ratio; MI, myocardial infarction; PCI, percutaneous coronary intervention; RR, relative risk; UFH, unfractionated heparin
Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada
Keywords: UFH، هپارین غیر اشباع شده; UFH, unfractionated heparin; LMWH, low molecular weight heparin; VTE, venous thromboembolism; Adm, admitting diagnosisAnticoagulants; Knowledge translation; Medical patients; Prevention; Venous thromboembolism